SURUNKALI VIRUSLI GEPATITNING SURUNKALI GLOMERULONEFRITNING KOMORBID KURSI BILAN RIVOJLANISHINING KLINIK VA BIOKIMYOVIY JIHATLARI.

Mardonov S. Y. & Fozilova M. Z.


Annotatsiya

Virusli gepatitda ikkilamchi glomerulyar shikastlanishlar sekin kechadi, ammo bemorlarning uchdan bir qismida bu jarayon barqaror rivojlanadi va buyrak etishmovchiligi namoyon bo‘lishi bilan bemorning ahvolini yomonlashtiradigan nefrotik sindrom sifatida namoyon bo‘ladi. Ushbu tadqiqotning maqsadi surunkali virusli gepatit B va C da buyraklarning funktsional holatiga zarar etkazishning klinik va biokimyoviy jihatlarini o‘rganishdir. Tadqiqotda ijobiy HBV va HCV serologik markerlari va buyrak shikastlanishining klinik va laboratoriya sindromlari bo‘lgan 198 bemor ishtirok etdi. .


Adabiyotlar

  1. American Diabetes Association. (2023). Classification and diagnosis of diabetes: Standards of care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S19–S40. https://doi.org/10.2337/dc23-S002
  2. Baynes, J. W., & Thorpe, S. R. (1999). Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes, 48(1), 1–9. https://doi.org/10.2337/diabetes.48.1.1
  3. Ceriello, A., & Motz, E. (2004). Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? Arteriosclerosis, Thrombosis, and Vascular Biology, 24(5), 816–823. https://doi.org/10.1161/01.ATV.0000122852.22604.78
  4. Desco, M. C., Asensi, M., Márquez, R., Martínez-Valls, J., Vento, M., Pallardó, F. V., & Viña, J. (2002). Xanthine oxidase is involved in free radical production in type 1 diabetes: Protection by allopurinol. Diabetes, 51(4), 1118–1124. https://doi.org/10.2337/diabetes.51.4.1118
  5. Giacco, F., & Brownlee, M. (2010). Oxidative stress and diabetic complications. Circulation Research, 107(9), 1058–1070. https://doi.org/10.1161/CIRCRESAHA.110.223545
  6. Lenzen, S. (2008). The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia, 51(2), 216–226. https://doi.org/10.1007/s00125-007-0886-7
  7. Palsamy, P., & Subramanian, S. (2008). Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2–Keap1 signaling. Biochimica et Biophysica Acta, 1782(5), 425–435. https://doi.org/10.1016/j.bbadis.2008.03.008
  8. Reed, L. J. (1974). Multienzyme complexes. Accounts of Chemical Research, 7(2), 40–46. https://doi.org/10.1021/ar50074a001
  9. Stacpoole, P. W. (2017). The pharmacology of dichloroacetate. Metabolism, 65(2), 229–238. https://doi.org/10.1016/j.metabol.2015.12.005
  10. Tang, S. M., Deng, X. T., Zhou, J., Li, Q. P., Ge, X. X., & Miao, L. (2019). Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomedicine & Pharmacotherapy, 121, 109604. https://doi.org/10.1016/j.biopha.2019.109604